Log in

Arcadia Biosciences Stock Forecast, Price & News

+0.23 (+7.85 %)
(As of 11/24/2020 12:00 AM ET)
Today's Range
Now: $3.16
50-Day Range
MA: $3.14
52-Week Range
Now: $3.16
Volume384,700 shs
Average Volume214,302 shs
Market Capitalization$34.23 million
P/E RatioN/A
Dividend YieldN/A
Arcadia Biosciences, Inc., a consumer-driven agricultural technology company, engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; nutritional oils; and HB4, a drought and herbicide tolerant soybean trait. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Canada, Africa, and India. The company was founded in 2002 and is headquartered in Davis, California.
Read More
Arcadia Biosciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.35 out of 5 stars

Industry, Sector and Symbol

Industry Agricultural production - crops
Current SymbolNASDAQ:RKDA



Sales & Book Value

Annual Sales$1.17 million
Book Value$0.96 per share


Net Income$-28,810,000.00
Net Margins-1,973.82%


Market Cap$34.23 million
Next Earnings Date3/24/2021 (Estimated)
OptionableNot Optionable
+0.23 (+7.85 %)
(As of 11/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RKDA News and Ratings via Email

Sign-up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Arcadia Biosciences (NASDAQ:RKDA) Frequently Asked Questions

How has Arcadia Biosciences' stock price been impacted by COVID-19 (Coronavirus)?

Arcadia Biosciences' stock was trading at $3.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, RKDA stock has decreased by 0.3% and is now trading at $3.16.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Arcadia Biosciences?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arcadia Biosciences in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Arcadia Biosciences

What stocks does MarketBeat like better than Arcadia Biosciences?

Wall Street analysts have given Arcadia Biosciences a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Arcadia Biosciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Arcadia Biosciences' next earnings date?

Arcadia Biosciences is scheduled to release its next quarterly earnings announcement on Wednesday, March 24th 2021.
View our earnings forecast for Arcadia Biosciences

How were Arcadia Biosciences' earnings last quarter?

Arcadia Biosciences, Inc. (NASDAQ:RKDA) announced its earnings results on Tuesday, November, 17th. The basic materials company reported ($0.60) earnings per share for the quarter, missing analysts' consensus estimates of ($0.54) by $0.06. Arcadia Biosciences had a negative net margin of 1,973.82% and a negative return on equity of 175.11%.
View Arcadia Biosciences' earnings history

When did Arcadia Biosciences' stock split? How did Arcadia Biosciences' stock split work?

Shares of Arcadia Biosciences reverse split before market open on Wednesday, January 24th 2018. The 1-20 reverse split was announced on Tuesday, January 23rd 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 23rd 2018. An investor that had 100 shares of Arcadia Biosciences stock prior to the reverse split would have 5 shares after the split.

What price target have analysts set for RKDA?

2 brokerages have issued 12-month target prices for Arcadia Biosciences' stock. Their forecasts range from $12.00 to $16.00. On average, they expect Arcadia Biosciences' stock price to reach $14.00 in the next year. This suggests a possible upside of 343.0% from the stock's current price.
View analysts' price targets for Arcadia Biosciences

Are investors shorting Arcadia Biosciences?

Arcadia Biosciences saw a decrease in short interest in the month of October. As of October 30th, there was short interest totaling 361,000 shares, a decrease of 32.8% from the October 15th total of 536,900 shares. Based on an average daily volume of 195,200 shares, the days-to-cover ratio is currently 1.8 days.
View Arcadia Biosciences' Short Interest

Who are some of Arcadia Biosciences' key competitors?

What other stocks do shareholders of Arcadia Biosciences own?

Who are Arcadia Biosciences' key executives?

Arcadia Biosciences' management team includes the following people:
  • Mr. Matthew T. Plavan, Pres, CEO & Director (Age 56, Pay $476.04k)
  • Ms. Pamela Haley, CFO & Corp. Sec. (Age 49, Pay $268.47k)
  • Dr. Randall Shultz Ph.D., Chief Technology Officer
  • Mr. Christopher Williams-Campbell, Head of People
  • Dr. Zhongjin Lu Ph.D., Director of Product Devel. (Age 54)
  • Mr. Kevin Hodges, VP of Commercial Operations

When did Arcadia Biosciences IPO?

(RKDA) raised $66 million in an initial public offering (IPO) on Friday, May 15th 2015. The company issued 8,200,000 shares at $8.00 per share. Credit Suisse, J.P. Morgan and Piper Jaffray served as the underwriters for the IPO.

What is Arcadia Biosciences' stock symbol?

Arcadia Biosciences trades on the NASDAQ under the ticker symbol "RKDA."

Who are Arcadia Biosciences' major shareholders?

Arcadia Biosciences' stock is owned by a number of retail and institutional investors. Top institutional shareholders include GSA Capital Partners LLP (0.94%), Ardsley Advisory Partners LP (0.23%) and LPL Financial LLC (0.21%). Company insiders that own Arcadia Biosciences stock include Kevin Comcowich, Lilian Shackelford Murray, Matthew T Plavan and Sarah Reiter.
View institutional ownership trends for Arcadia Biosciences

Which major investors are buying Arcadia Biosciences stock?

RKDA stock was acquired by a variety of institutional investors in the last quarter, including GSA Capital Partners LLP, Ardsley Advisory Partners LP, and LPL Financial LLC. Company insiders that have bought Arcadia Biosciences stock in the last two years include Kevin Comcowich, Lilian Shackelford Murray, Matthew T Plavan, and Sarah Reiter.
View insider buying and selling activity for Arcadia Biosciences

How do I buy shares of Arcadia Biosciences?

Shares of RKDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Arcadia Biosciences' stock price today?

One share of RKDA stock can currently be purchased for approximately $3.16.

How big of a company is Arcadia Biosciences?

Arcadia Biosciences has a market capitalization of $34.23 million and generates $1.17 million in revenue each year. The basic materials company earns $-28,810,000.00 in net income (profit) each year or ($3.37) on an earnings per share basis. Arcadia Biosciences employs 41 workers across the globe.

What is Arcadia Biosciences' official website?

The official website for Arcadia Biosciences is www.arcadiabio.com.

How can I contact Arcadia Biosciences?

Arcadia Biosciences' mailing address is 202 COUSTEAU PLACE SUITE 105, DAVIS CA, 85018. The basic materials company can be reached via phone at 530-756-7077 or via email at [email protected]

This page was last updated on 11/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.